207 related articles for article (PubMed ID: 21340470)
21. Differential adaptive properties of accumbens shell dopamine responses to ethanol as a drug and as a motivational stimulus.
Bassareo V; De Luca MA; Aresu M; Aste A; Ariu T; Di Chiara G
Eur J Neurosci; 2003 Apr; 17(7):1465-72. PubMed ID: 12713649
[TBL] [Abstract][Full Text] [Related]
22. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
Szumlinski KK; Maisonneuve IM; Glick SD
Brain Res; 2000 May; 864(1):13-23. PubMed ID: 10793182
[TBL] [Abstract][Full Text] [Related]
23. Post-treatment of dextromethorphan reverses morphine effect on conditioned place preference in rats.
Lue WM; Huang EY; Yang SN; Wong CS; Tao PL
Synapse; 2007 Jun; 61(6):420-8. PubMed ID: 17372963
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal effects of response contingent and noncontingent intravenous heroin on in vivo nucleus accumbens shell versus core dopamine in the rat: a repeated sampling microdialysis study.
Lecca D; Valentini V; Cacciapaglia F; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2007 Sep; 194(1):103-16. PubMed ID: 17541779
[TBL] [Abstract][Full Text] [Related]
25. Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat.
Lecca D; Cacciapaglia F; Valentini V; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2007 Apr; 191(3):653-67. PubMed ID: 16932924
[TBL] [Abstract][Full Text] [Related]
26. Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence.
Erhardt A; Sillaber I; Welt T; Müller MB; Singewald N; Keck ME
Neuropsychopharmacology; 2004 Nov; 29(11):2074-80. PubMed ID: 15187982
[TBL] [Abstract][Full Text] [Related]
27. Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine.
Cadoni C; Di Chiara G
Eur J Pharmacol; 2000 Jan; 387(3):R23-5. PubMed ID: 10650185
[TBL] [Abstract][Full Text] [Related]
28. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens.
Ventura R; Alcaro A; Puglisi-Allegra S
Cereb Cortex; 2005 Dec; 15(12):1877-86. PubMed ID: 15728739
[TBL] [Abstract][Full Text] [Related]
29. Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine.
Beyer CE; Steketee JD
Brain Res; 1999 Jul; 833(2):133-41. PubMed ID: 10375688
[TBL] [Abstract][Full Text] [Related]
30. Facilitation of sexual behavior and enhanced dopamine efflux in the nucleus accumbens of male rats after D-amphetamine-induced behavioral sensitization.
Fiorino DF; Phillips AG
J Neurosci; 1999 Jan; 19(1):456-63. PubMed ID: 9870973
[TBL] [Abstract][Full Text] [Related]
31. Prefrontal cortex serotonin, stress, and morphine-induced nucleus accumbens dopamine.
Bland ST; Schmid MJ; Watkins LR; Maier SF
Neuroreport; 2004 Dec; 15(17):2637-41. PubMed ID: 15570168
[TBL] [Abstract][Full Text] [Related]
32. Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum.
Bassareo V; Di Chiara G
J Neurosci; 1997 Jan; 17(2):851-61. PubMed ID: 8987806
[TBL] [Abstract][Full Text] [Related]
33. The γ-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens.
Fu Z; Yang H; Xiao Y; Zhao G; Huang H
Behav Brain Funct; 2012 Jul; 8():20. PubMed ID: 22559224
[TBL] [Abstract][Full Text] [Related]
34. Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat.
Bassareo V; Tanda G; Petromilli P; Giua C; Di Chiara G
Psychopharmacology (Berl); 1996 Apr; 124(4):293-9. PubMed ID: 8739543
[TBL] [Abstract][Full Text] [Related]
35. Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment.
Amato D; Natesan S; Yavich L; Kapur S; Müller CP
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1327-39. PubMed ID: 21281560
[TBL] [Abstract][Full Text] [Related]
36. The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release.
Bland ST; Hutchinson MR; Maier SF; Watkins LR; Johnson KW
Brain Behav Immun; 2009 May; 23(4):492-7. PubMed ID: 19486648
[TBL] [Abstract][Full Text] [Related]
37. Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats.
Johnson DW; Glick SD
Pharmacol Biochem Behav; 1993 Oct; 46(2):341-7. PubMed ID: 8265688
[TBL] [Abstract][Full Text] [Related]
38. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
[TBL] [Abstract][Full Text] [Related]
39. Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence.
Bassareo V; Tanda G; Di Chiara G
Psychopharmacology (Berl); 1995 Nov; 122(2):202-5. PubMed ID: 8848538
[TBL] [Abstract][Full Text] [Related]
40. Chronic morphine induces long-lasting changes in acetylcholine release in rat nucleus accumbens core and shell: an in vivo microdialysis study.
Fiserová M; Consolo S; Krsiak M
Psychopharmacology (Berl); 1999 Feb; 142(1):85-94. PubMed ID: 10102787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]